Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Market Cap	40.95M
Revenue (ttm)	81.16M
Net Income (ttm)	3.61M
Shares Out	35.00M
EPS (ttm)	0.10
PE Ratio	11.35
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,856
Average Volume	17,833
Open	1.150
Previous Close	1.180
Day's Range	1.150 - 1.170
52-Week Range	1.140 - 1.410
Beta	0.24
RSI	27.14
Earnings Date	Mar 26, 2025

About ASE:DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. It operates through Medicine; and Infants’ Cereals and Milk Formula segments. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatolog...

• Industry: Pharmaceutical Preparations
• Founded: 1975
• Employees: 1,067
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: DADI

Financial Performance

In 2024, ASE:DADI's revenue was 81.16 million, an increase of 8.39% compared to the previous year's 74.88 million. Earnings were 3.61 million, an increase of 14.16%.